|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,825.00 JPY | -1.03% |
|
+10.14% | +23.64% |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 14TCr | 27TCr | 36TCr | 37TCr | 33TCr | |||||
Total Revenues | 14TCr | 27TCr | 36TCr | 37TCr | 33TCr | |||||
Cost of Goods Sold, Total | 12TCr | 22TCr | 30TCr | 30TCr | 27TCr | |||||
Gross Profit | 1.98TCr | 5.02TCr | 6.29TCr | 6.53TCr | 5.8TCr | |||||
Selling General & Admin Expenses, Total | 1.56TCr | 1.82TCr | 2.46TCr | 2.7TCr | 2.77TCr | |||||
Provision for Bad Debts | 20L | 1.2Cr | 60L | - | -70L | |||||
Depreciation & Amortization - (IS) | 17Cr | 19Cr | 22Cr | 22Cr | 25Cr | |||||
Other Operating Expenses, Total | 1.58TCr | 1.84TCr | 2.48TCr | 2.72TCr | 2.79TCr | |||||
Operating Income | 399.6Cr | 3.18TCr | 3.81TCr | 3.81TCr | 3.01TCr | |||||
Interest Expense, Total | -2.6Cr | -2.7Cr | -1.8Cr | -1.4Cr | -2.8Cr | |||||
Interest And Investment Income | 32Cr | 41Cr | 60Cr | 68Cr | 97Cr | |||||
Net Interest Expenses | 29Cr | 38Cr | 58Cr | 66Cr | 94Cr | |||||
Currency Exchange Gains (Loss) | 25Cr | 86Cr | 16Cr | 59Cr | - | |||||
Other Non Operating Income (Expenses) | 46Cr | 41Cr | 45Cr | 40Cr | 56Cr | |||||
EBT, Excl. Unusual Items | 499.4Cr | 3.34TCr | 3.93TCr | 3.97TCr | 3.16TCr | |||||
Gain (Loss) On Sale Of Investments | - | - | 10L | 22Cr | - | |||||
Gain (Loss) On Sale Of Assets | 1.7Cr | 10L | -60Cr | -95Cr | -105.1Cr | |||||
Asset Writedown | -72Cr | -54Cr | - | - | - | |||||
Other Unusual Items | - | - | 10L | 78Cr | -85Cr | |||||
EBT, Incl. Unusual Items | 429.3Cr | 3.29TCr | 3.87TCr | 3.98TCr | 2.97TCr | |||||
Income Tax Expense | -159.6Cr | 94Cr | 780.7Cr | 1.18TCr | 850.5Cr | |||||
Earnings From Continuing Operations | 588.9Cr | 3.19TCr | 3.08TCr | 2.8TCr | 2.12TCr | |||||
Net Income to Company | 588.9Cr | 3.19TCr | 3.08TCr | 2.8TCr | 2.12TCr | |||||
Net Income - (IS) | 588.9Cr | 3.19TCr | 3.08TCr | 2.8TCr | 2.12TCr | |||||
Net Income to Common Incl Extra Items | 588.9Cr | 3.19TCr | 3.08TCr | 2.8TCr | 2.12TCr | |||||
Net Income to Common Excl. Extra Items | 588.9Cr | 3.19TCr | 3.08TCr | 2.8TCr | 2.12TCr | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 48.03 | 269.79 | 272.44 | 253.51 | 197.96 | |||||
Basic EPS - Continuing Operations | 48.03 | 269.79 | 272.44 | 253.51 | 197.96 | |||||
Basic Weighted Average Shares Outstanding | 12Cr | 12Cr | 11Cr | 11Cr | 11Cr | |||||
Net EPS - Diluted | 48.03 | 269.79 | 272.44 | 253.51 | 197.96 | |||||
Diluted EPS - Continuing Operations | 48.03 | 269.79 | 272.44 | 253.51 | 197.96 | |||||
Diluted Weighted Average Shares Outstanding | 12Cr | 12Cr | 11Cr | 11Cr | 11Cr | |||||
Normalized Basic EPS | 25.46 | 176.48 | 216.68 | 225.09 | 184.46 | |||||
Normalized Diluted EPS | 25.46 | 176.48 | 216.68 | 225.09 | 184.46 | |||||
Payout Ratio | 34 | 6.71 | 12.95 | 17.81 | 25.51 | |||||
Supplemental Items | ||||||||||
EBITDA | 955.9Cr | 3.63TCr | 4.31TCr | 4.4TCr | 3.69TCr | |||||
EBITA | 399.6Cr | 3.18TCr | 3.81TCr | 3.81TCr | 3.01TCr | |||||
EBIT | 399.6Cr | 3.18TCr | 3.81TCr | 3.81TCr | 3.01TCr | |||||
Effective Tax Rate - (Ratio) | -37.18 | 2.87 | 20.2 | 29.7 | 28.63 | |||||
Normalized Net Income | 312.12Cr | 2.09TCr | 2.45TCr | 2.48TCr | 1.98TCr | |||||
Non-Cash Pension Expense | 11Cr | -6.3Cr | -7.5Cr | -8Cr | -25Cr | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 1.24TCr | 1.46TCr | 2.02TCr | 2.21TCr | 2.25TCr | |||||
Research And Development Expense From Footnotes | 18Cr | 16Cr | 17Cr | 46Cr | 28Cr |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















